Studies on the effects of 4-hydroxy isoleucine in experimentally induced inflammatory bowel disease
DOI:
https://doi.org/10.7439/ijpr.v6i5.3289Abstract
Objective: The present study was designed to evaluate the effects of 4-Hydroxyisoleucine in experimentally induced Inflammatory Bowel Disease (IBD) in rats. Method: Wistar Albino rats weighing about 150-250 gm were employed in the study for induction of acetic acid and indomethacin induced IBD and assessed for various parameters like body weight, colon and intestinal damage, oxidative stress, total proteins and inflammation. Results: In this study 4-hydroxyisoleucine at two different doses was found to be successful in managing the serum and tissue homogenate changes in acetic acid induced UC and indomethacin induced CD possibly through its antioxidant and anti-inflammatory profile. Conclusions: 4-hydroxyisoleucine proved its antioxidant and anti-inflammatory profile by reducing the oxidative stress and inflammation, further it also improved the integrity of intestine thus amino acid, 4-hydroxyisoleucine was successful in mediating the changes induced by acetic acid and indomethacin induced experimental IBD in rats.Downloads
References
Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol 2001; 7:175
Qin X. Etiology of inflammatory bowel disease: a unified hypothesis. World J Gastroenterol. 2012; 18:1708-22.
Lee YM, Fock K, See SJ, Ng T, Khor C, Teo EK. Racial differences in the prevalence of ulcerative colitis and Crohn
Molodecky NA, Kaplan CG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol. 2010; 6:339-46.
Strober W, L
Tabassum N, Hamdani M and Najar IH. Natural Treatment for Inflammatory Bowel Disease. British Biomedical Bulletin. 2014; 2: 85-94.
Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmud N, Smith OP. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm. 2004; 13:181-7.
Mehrabani D, Ziaei M, Hosseini SV, Ghahramani L, Bananzadeh AM, Ashraf MJ, Amini A, Amini M, Tanideh N.The effect of calendula officinalis in therapy of acetic acid induced ulcerative colitis in dog as an animal model. Iran Red Crescent Med J. 2011; 13:884-90.
Carty E, De Brabander M, Feakins RM, Rampton DS. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper. Gut. 2000; 46:487-92.
Loguercio C, D'Argenio G, Delle Cave M, Cosenza V, Della Valle N, Mazzacca G, del Vecchio Blanco C. Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Dig Dis Sci. 1996; 41:1204-11.
Baumgart DC, Sandborn WJ. Crohn
Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002; 347:417-29.
Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I, Pochart P, Dor
Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol. 2003; 98:363-8.
Bengtson MB, Solberg C, Aamodt G, Sauar J, Jahnsen J, Moum B, Lygren I, Vatn MH. Familial aggregation in Crohn
Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases. Lancet. 2006; 367:1271
Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003; 3: 521-33.
Pedersen J, Coskun M, Soendergaard C, Salem M, and Nielsen OH, Inflammatory pathways of importance for management of inflammatory bowel disease; World J Gastroenterol. 2014; 20: 64
Bamias G, Nyce MR, De La Rue SA, Cominelli F. New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med. 2005; 143: 895-904.
Biplab Adhikary, Sudhir kumar yadav, Kshama Roy, Sandip K., Bandyopadhyay, Subrata Chattopadhyay. Black tea and theaflavins assist healing of indomethacin induced gastric ulceration in mice by antioxidative action 2011; article id 546560,11 pages.
Cheung DY, Kim JI, Park SH, and Kim. JK, Proanthocyanidin from grape seed extracts protects indomethacin-induced small intestinal mucosal injury. Hindawi Publishing Corporation Gastroenterology Research and Practice. 2014; 10:115.
Deshmukh CD, Veeresh B, PawarAT. Protective effect of Emblica officinalis fruit extract on acetic acid induced colitis in rats. J. Herbal Medicine and Toxicology. 2010; 4: 83-7.
Jagtap, A.G., Shirke, S.S., Phadke, A.S. Effect of polyherbal formulation on experimental models of inflammatory bowel disease. J Ethnopharmacol. 2004; 90: 195-204.
Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004; 50: 81-92.
Stadnicki, A, Colman, RW. Experimental models of inflammatory bowel disease. Arch Immunol Ther Exp (Warsz). 2003; 51:149-55.
Nagano Y, Matsui H, Muramatsu M, et al: Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells. Dig Dis Sci. 2005; 50:S76-83.
Fuji Y, Matsura T, Kai M, Kawasaki H Yamada K. Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells. Jpn J Pharmacol 2000; 84:63-70.
Chattopadhyay I, Bandyopadhyay U, Biswas K, Maity P, Banerjee RK. Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen. Free Radic Bio Med. 2006; 40:1397
Nagai N, Fukuhata T, Ito Y, Usui S, Hirano K. Involvement of interleukin 18 in indomethacin-induced lesions of the gastric mucosa in adjuvant-induced arthritis rat. Toxicology 2009; 255:124
Fukumoto K, Naito Y, Takagi T, Yamada S, et al. Role of tumor necrosis factor-? in the pathogenesis of indomethacin-induced small intestinal injury in mice., Int J Mol Med. 2011; 27:353-9.
Sindhu G, Ratheesh M, Shyni GL, Nambisan B, Helen A. Anti-inflammatory and antioxidative effects of mucilage of Trigonella foenum graecum (Fenugreek) on adjuvant induced arthritic rats. Int Immunopharmacol. 2012; 12:205-11.
Hartmann RM, Morgan Martins MI, Tieppo J, Fillmann HS, Marroni NP. Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acid. Dig Dis Sci. 2012; 57: 2038-44.
Daneshmand A, Rahimian R, Mohammadi H, Ejtemaee-Mehr S, Tavangar SM, Babaei Kelishomi R, Dehpour AR. Protective effects of lithium on acetic acid-induced colitis in rats. Dig Dis Sci. 2009; 54:1901-7.
Kannan N, Guruvayoorappan C. Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators. Int Immuno Pharmacol. 2013; 16:57-66.
Mahgoub A, El-Medany A, Mustafa A, Arafah M, Moursi M. Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. Toxicol Appl Pharmacol. 2005; 205: 43-52.
Baquer NZ, Kumar P, Taha A, Kale RK, Cowsik SM, McLean P. Metabolic and molecular action of Trigonella foenum graecum (fenugreek) and trace metals in experimental diabetic tissues. J Biosci.2011; 36:383-96.
Kaviarasan S, Ramamurty, GunasekaranP,Varalakshmi E and Anuradha CV. Fenugreek (Trigonella foenum graecum) seed extract prevents ethanol-induced toxicity and apoptosis in liver cells. Alcohol & Alcohol. 2006; 41:267
Meghwal M and Goswami TK. A Review on the functional properties, nutritional content, medicinal utilization and potential application of fenugreek. J Food Process Technol. 2012; 3:9.
Moghadam FH, Vakili-Zarch B, Shafiee M, Mirjalili A. Fenugreek seed extract treats peripheral neuropathy in pyridoxine induced neuropathic mice. EXCL Journal. 2013; 12:282-90.
Madar Z. and Shomer I. Polysaccharide fraction of composition of a gel fraction derived from fenugreek and its effect on starch digestion and bile acid absorption in rats. J. Agricultural Food Nutrition. 1990; 38:143-47.
Mandegary A, Pournamdari M, Sharififar F, Mohammadia S, Fardiar R, Shooli S. Alkaloid and flavonoid rich fractions of fenugreek seeds (Trigonella foenum-graecum L.) with antinociceptive and anti-inflammatory effects. Food Chemical Toxicol. 2012; 50: 2503
Helmy HM. Study the effect of fenugreek seeds on gastric ulcer in experimental rats. World Journal of Dairy & Food Sciences. 2011; 6: 152-8.
Gaur V, Bodhankar SL, Mohan V, Thakur desai P.Antidepressant-like effect of 4-hydroxyisoleucine from Trigonella foenum graecum seeds in mice. Biomedicine & Aging Pathology 2012; 2:121
Kawabata T, Cui MY, Hasegawa T, Takano F, Ohta T. Anti-inflammatory and anti-melanogenic steroidal saponin glycosides from Fenugreek (Trigonella foenum graecum) seeds. Planta Med. 2011; 77:705-10.
Jett
Millar AD, Rampton DS, Chander CL, Claxson AW et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. 1996; 39:407-15.
Ohkawa H, Onishi N, Yagi K. Assay of lipid peroxidation in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351-8.
Jollow, D.J, Michell, J.R, Zampaglionic ,Gillete. Bromoibenzene-induced Liver necrosis: Protective role of glutathione and evidence for 3,4-Bromobenzene oxide as hepatotoxic metabolite. Pharmacology. 1974; 11:151-69.
Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004; 53:v1-6.
Paiva LA, Gurgel LA, Silva RM, Tome AR et al. Anti-inflammatory effect of kaurenoic acid, a diterpene from langsdorffii on acetic acid-induced colitis in rats. Vascul Pharmacol. 2002; 39:303-7.
Mizuno H, Sakamoto C, Matsuda K, Wada K et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology. 1997; 112: 387-97.
Noa M, M
Sasaki S, Hirata I, Maemura K, Hamamoto N, Murano M, Toshina K, Katsu K. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand J Immunol. 2000; 51:23-8.
Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ laminapropria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increasedsecretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996; 157:1261-70.
Bitiren M, Karakilcik AZ, Zerin M, Ozardali I et al. Protective effects of selenium and vitamin E combination on experimental colitis in blood plasma and colon of rats. Biol Trace Elem Res. 2010; 136:87-95.
Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002; 82:47-95.
Kruidenier L, Verspaget HW. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease. Aliment Pharmacol Ther. 2002; 16:1997-2015.
Thippeswamy BS, Mahendran S, Biradar et al. Protective effect of embelin against acetic acid induced ulcerative colitis in rats. European Journal of Pharmacology, 2011; 654:100
Pucilowska JB, Williams KL, Lund PK. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2000; 279:G65.
Abimosleh SM, Tran CD, Howarth GS. Emu Oil Reduces Small Intestinal Inflammation in the Absence of Clinical Improvement in a Rat Model of Indomethacin-Induced Enteropathy. Hindwai Pub. 2013; 2013:1-10.
Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003; 111:1805
Kushner I. C-reactive protein in rheumatology. Arthritis Rheum. 1991; 34:1065
Vermeire S , Aasschae GV, Rutgeerts P. Laboratory markers in IBD : usefull magic , or unnecessary toys?. Gut. 2006; 55: 426-31.
Brignola C, Campieri M, Bazzocchi G et al. A laboratory index for predicting relapse in asymptomatic patients with Crohn
Boirivant M, Leoni M, Tariciotti D et al. The clinical significance of serum C reactive protein levels in Crohn
Cindie Slightam, Total protein test, 2012.( http://www.healthline.com/health/total-protein#Overview1)
Pawar S.H., Shete R.V., Patil B.M., Pattankude V.S., Otari K.V. and Kore K.J. Effect off glycyrrhzic acid, ammonium salt in experimental animal models of inflammatory bowel disease. 2010; 1:479-91.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article